Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22523655 | 1.00 | CA12 (0.34) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL23238042 | 0.96 | CA12 (0.33) | CA12CA1CA2CA9ALOX5 | |
| SCHEMBL22523667 | 0.95 | CA12 (0.33) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL23867226 | 0.95 | CA12 (0.32) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL22523207 | 0.94 | CA12 (0.32) | CA12CA1CA2CA9ALOX5 | |
| SCHEMBL23232653 | 0.94 | CA12 (0.33) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL23233201 | 0.94 | ALOX5 (0.32) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL22523453 | 0.94 | CA12 (0.34) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL22523708 | 0.94 | CA12 (0.34) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL23239192 | 0.93 | CA12 (0.32) | CA12CA1CA2CA9ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548877-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20200317653-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548877-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device, and electronic device | OR10J3, PIEZO1, RER1 | CA12 3932/4885CA1 3533/4885CA2 4041/4885 |
| US-20200317653-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | OR10J3, PIEZO1, RER1 | CA12 3932/4885CA1 3533/4885CA2 4041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.